Mayflower Financial Advisors LLC bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 431 shares of the biotechnology company's stock, valued at approximately $256,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AXON. Groupama Asset Managment acquired a new position in shares of Axon Enterprise in the third quarter valued at about $200,000. Massachusetts Financial Services Co. MA acquired a new position in Axon Enterprise in the 3rd quarter worth approximately $120,553,000. International Assets Investment Management LLC purchased a new position in Axon Enterprise during the 3rd quarter worth approximately $871,860,000. Westfield Capital Management Co. LP lifted its stake in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company's stock valued at $469,661,000 after acquiring an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. lifted its stake in Axon Enterprise by 328.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company's stock valued at $86,354,000 after acquiring an additional 111,405 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Julie A. Cullivan sold 1,261 shares of the business's stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock worth $30,721,337 over the last quarter. 6.10% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Several research analysts recently issued reports on the stock. JMP Securities raised their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a "market outperform" rating in a report on Thursday, October 31st. Needham & Company LLC lifted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a research note on Friday, November 8th. Robert W. Baird upped their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. TD Cowen assumed coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a "buy" rating and a $700.00 target price on the stock. Finally, Northland Securities boosted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an "outperform" rating in a report on Monday, November 11th. One equities research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $524.85.
Get Our Latest Research Report on Axon Enterprise
Axon Enterprise Price Performance
Axon Enterprise stock traded up $13.46 during midday trading on Thursday, reaching $653.43. The company had a trading volume of 536,604 shares, compared to its average volume of 565,590. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 12-month low of $247.04 and a 12-month high of $698.67. The company has a market capitalization of $49.82 billion, a P/E ratio of 168.85, a P/E/G ratio of 6.09 and a beta of 1.04. The firm's fifty day simple moving average is $618.90 and its 200-day simple moving average is $477.78.
Axon Enterprise Company Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.